News
-
-
-
-
PRESS RELEASE
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding a decrease in shareholding percentage. The company is focused on technology-enabled clinical research and software platform -
-
-
PRESS RELEASE
Oxurion expands its clinical research platform through strategic biometrics partnership between Axiodis CRO and KYomed INNOV
Oxurion NV announces strategic partnership with KYomed INNOV & CEISO for specialist biometrics services in clinical development, aiming to optimize study design and data quality -
-
-